文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Corrigendum: Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic review.勘误：食管癌中免疫检查点抑制剂与胸部放疗联合应用的毒性特征：一项荟萃分析和系统评价。

Front Immunol. 2023 Apr 11;14:1193710. doi: 10.3389/fimmu.2023.1193710. eCollection 2023.

2

Corrigendum: The Significance of Transarterial Chemo(embolization) Combined With Tyrosine Kinase Inhibitors and Immune Check Point Inhibitors for Unresectable Hepatocellular Carcinoma in the Era of Systemic Therapy: A Systematic Review.勘误：经动脉化疗（栓塞）联合酪氨酸激酶抑制剂和免疫检查点抑制剂在全身治疗时代对不可切除肝细胞癌的意义：一项系统评价。

Front Immunol. 2022 Jun 7;13:952446. doi: 10.3389/fimmu.2022.952446. eCollection 2022.

3

Corrigendum: The efficacy and safety analysis of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma.勘误：一线免疫检查点抑制剂治疗肺肉瘤样癌的疗效与安全性分析

Front Immunol. 2023 Sep 6;14:1269596. doi: 10.3389/fimmu.2023.1269596. eCollection 2023.

4

Toxicity Profile of Combining PD-1/PD-L1 Inhibitors and Thoracic Radiotherapy in Non-Small Cell Lung Cancer: A Systematic Review.联合 PD-1/PD-L1 抑制剂和胸部放疗治疗非小细胞肺癌的毒性特征：系统评价。

Front Immunol. 2021 Mar 30;12:627197. doi: 10.3389/fimmu.2021.627197. eCollection 2021.

5

Corrigendum: Peripheral blood lymphocyte subsets predict the efficacy of immune checkpoint inhibitors in non- small cell lung cancer.勘误：外周血淋巴细胞亚群可预测免疫检查点抑制剂在非小细胞肺癌中的疗效。

Front Immunol. 2022 Dec 8;13:1111230. doi: 10.3389/fimmu.2022.1111230. eCollection 2022.

6

Corrigendum: Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies.勘误：肝脏和胰腺恶性肿瘤中的肿瘤浸润性T细胞状态及检查点抑制剂表达

Front Immunol. 2023 Mar 23;14:1177713. doi: 10.3389/fimmu.2023.1177713. eCollection 2023.

7

Corrigendum: Alveolar macrophages in lung cancer: opportunities and challenges.勘误：肺癌中的肺泡巨噬细胞：机遇与挑战

Front Immunol. 2023 Nov 6;14:1328927. doi: 10.3389/fimmu.2023.1328927. eCollection 2023.

8

Corrigendum: Immune Responses to Gametocyte Antigens in a Malaria Endemic Population-The African Context: A Systematic Review and Meta-Analysis.勘误：疟疾流行地区人群对配子体抗原的免疫反应——非洲背景：一项系统评价和荟萃分析

Front Immunol. 2020 Mar 23;11:389. doi: 10.3389/fimmu.2020.00389. eCollection 2020.

9

Corrigendum: Innate Immune Cells in the Esophageal Tumor Microenvironment.勘误：食管肿瘤微环境中的固有免疫细胞

Front Immunol. 2021 May 27;12:708705. doi: 10.3389/fimmu.2021.708705. eCollection 2021.

10

Corrigendum: Targeting myeloid checkpoint molecules in combination with antibody therapy: A novel anti-cancer strategy with IgA antibodies?勘误：联合抗体疗法靶向髓系检查点分子：一种使用IgA抗体的新型抗癌策略？

Front Immunol. 2022 Sep 13;13:1017924. doi: 10.3389/fimmu.2022.1017924. eCollection 2022.

勘误：食管癌中免疫检查点抑制剂与胸部放疗联合应用的毒性特征：一项荟萃分析和系统评价。

Corrigendum: Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic review.

作者信息

Xu Tongzhen, Liu Yunsong, Lu Xiaotong, Liang Jun

机构信息

Department of Radiotherapy Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Department of Radiotherapy Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China.

出版信息

Front Immunol. 2023 Apr 11;14:1193710. doi: 10.3389/fimmu.2023.1193710. eCollection 2023.

DOI:10.3389/fimmu.2023.1193710

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10123867/

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.1039020.].

摘要

[本文更正了文章的数字对象标识符：10.3389/fimmu.2022.1039020。]